Therefore, it is necessary to comprehensively understand the expression of PD‐L1 and TILs in the tumor immune microenvironment of ESCC and their interdependence to explore more reliable prognostic immune factors to predict the prognosis of patients with ESCC. Here, CD274 is linked to neoplasm.